SCHEMBL6318672

SCHEMBL6318672

COc1ccc(OC[CH]C2CC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.45
KDM4E B2RXH2 1/20 0.44
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
APP P05067 2/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169930 0.82 CHRNB4 (0.49) APP
SCHEMBL5145798 0.73 CA1 (0.52) TDP1KDM4ECA12CA1CA2
SCHEMBL705520 0.72 AOC3 (0.43) TDP1
1-Allyloxy-4-Methoxybenzene SCHEMBL2843640 0.71 ALDH1A1 (0.57) CA12CA1CA2CA7CA9
SCHEMBL1951879 0.71 ALDH1A1 (0.52) CA12CA1CA2CA7CA9
SCHEMBL1069709 0.69 LMNA (0.48) KDM4ECA12CA1CA2CA7
SCHEMBL1069708 0.69 LMNA (0.48) KDM4ECA12CA1CA2CA7
SCHEMBL16838742 0.69 TDP1 (0.73) TDP1CA12CA1CA2CA7
SCHEMBL8055688 0.69 ALDH1A1 (0.50) KDM4ECA12CA1CA2CA7
SCHEMBL2474020 0.69 KDM4E (0.60) TDP1KDM4ECA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501830-A1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES Actelion Pharmaceuticals Ltd. (CH) 2005-02-02 EP disclosed
WO-2003093267-A1 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2003-11-13 WO disclosed